PRODH and neoplasm: We are the first researchers to demonstrate that celecoxib affects proline metabolism, causes the induction of apoptosis through increased expression of pro-apoptotic factors (PRODH/POX and PPARγ) and reduction of HIF-1α, which indicates the potential of this drug to inhibit tumour growth, tumour invasion and angiogenesis.